{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T23:59:22Z","timestamp":1783468762147,"version":"3.55.0"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2012,7,25]],"date-time":"2012-07-25T00:00:00Z","timestamp":1343174400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Neurol Sci"],"published-print":{"date-parts":[[2013,6]]},"DOI":"10.1007\/s10072-012-1159-x","type":"journal-article","created":{"date-parts":[[2012,7,24]],"date-time":"2012-07-24T06:02:54Z","timestamp":1343109774000},"page":"919-924","source":"Crossref","is-referenced-by-count":17,"title":["The high frequency and clinical feature of seronegative myasthenia gravis in Southern China"],"prefix":"10.1007","volume":"34","author":[{"given":"Hui-yu","family":"Feng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hai-yan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-bin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue-tao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuan-ming","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2012,7,25]]},"reference":[{"key":"1159_CR1","first-page":"386","volume":"4","author":"X Zhang","year":"2007","unstructured":"Zhang X, Yang M, Xu J, Zhang M, Lang B, Wang W, Vincent A (2007) Clinical and serological study of myasthenia gravis in HuBei Province China. J Neurol Neurosurg Psychiatry 4:386\u2013390","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1159_CR2","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.20061","volume":"4","author":"J McConville","year":"2004","unstructured":"McConville J, Farrugia ME, Beeson D, Kishore U, Metcalfe R, Newsom-Davis J, Vincent A (2004) Detection and characterization of MuSk antibodies in seronegative myasthenia gravis. Ann Neurol 4:580\u2013584","journal-title":"Ann Neurol"},{"key":"1159_CR3","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/mus.20854","volume":"5","author":"KH Chan","year":"2007","unstructured":"Chan KH, Lachance DH, Harper CM, Lennon VA (2007) Frequency of seronegativity in adult-acquired generalized myasthenia gravis. Muscle Nerve 5:651\u2013658","journal-title":"Muscle Nerve"},{"key":"1159_CR4","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","volume":"3","author":"W Hoch","year":"2001","unstructured":"Hoch W, McConville J, Helms S, Newsom-Davis J, Melms A, Vincent A (2001) Auto-antibodies to the receptor tyrosine kinase MuSk in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat Med 3:365\u2013368","journal-title":"Nat Med"},{"key":"1159_CR5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1097\/01.wco.0000180660.57801.3f","volume":"5","author":"A Vincent","year":"2005","unstructured":"Vincent A, Leite MI (2005) Neuromuscular junction autoimmune disease: muscle specific kinase antibodies and treatments for myasthenia gravis. Curr Opin Neurol 5:519\u2013525","journal-title":"Curr Opin Neurol"},{"key":"1159_CR6","first-page":"16","volume":"1\u20132","author":"WB Liu","year":"2007","unstructured":"Liu WB, Xia Q, Men LN, Wu ZK, Huang RX (2007) Dysphonia as a primary manifestation in myasthenia gravis (MG): a retrospective review of 7 cases among 1,520 MG patients. J Neurol Sci 1\u20132:16\u201322","journal-title":"J Neurol Sci"},{"key":"1159_CR7","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1212\/01.WNL.0000128042.28877.C3","volume":"11","author":"JH Yeh","year":"2004","unstructured":"Yeh JH, Chen WH, Chiu HC, Vincent A (2004) Low frequency of MuSk antibody in generalized seronegative myasthenia gravis among Chinese. Neurology 11:2131\u20132132","journal-title":"Neurology"},{"key":"1159_CR8","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1136\/jnnp.2006.109488","volume":"10","author":"N Tsinzerling","year":"2007","unstructured":"Tsinzerling N, Lefvert AK, Matell G, Pirskanen-Matell R (2007) Myasthenia gravis: a long term follow-up study of Swedish patients with specific reference to thymic histology. J Neurol Neurosurg Psychiatry 10:1109\u20131112","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"1159_CR9","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cccn.2005.05.035","volume":"1\u20132","author":"R Hewer","year":"2006","unstructured":"Hewer R, Matthews I, Chen S, McGrath V, Evans M, Roberts E, Nute S, Sanders J, Furmaniak J, Smith BR (2006) A sensitive non-isotopic assay for acetylcholine receptor autoantibodies. Clin Chim Acta 1\u20132:159\u2013166","journal-title":"Clin Chim Acta"},{"key":"1159_CR10","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1093\/clinchem\/36.6.911","volume":"6","author":"M Ohta","year":"1990","unstructured":"Ohta M, Ohta K, Mori F, Itoh N, Nishitani H, Hayashi K (1990) Improved radioassay of anti-acetylcholine receptor antibody: application for the detection of extremely low antibody titers in sera from patients with myasthenia gravis. Clin Chem 6:911\u2013913","journal-title":"Clin Chem"},{"key":"1159_CR11","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/brain\/103.3.579","volume":"3","author":"DA Compston","year":"1980","unstructured":"Compston DA, Vincent A, Newsom-Davis J, Batchelor JR (1980) Clinical, pathological, HLA antigen and immunological evidence for disease heterogeneity in maysthenia gravis. Brain 3:579\u2013601","journal-title":"Brain"},{"key":"1159_CR12","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1212\/WNL.37.12.1854","volume":"12","author":"HC Chiu","year":"1987","unstructured":"Chiu HC, Vincent A, Newsom-Davis J, Hsieh KH, Hung T (1987) Myasthenia gravis: population differences in disease expression and acetylcholine receptor antibody titers between Chinese and Caucasians. Neurology 12:1854\u20131857","journal-title":"Neurology"},{"key":"1159_CR13","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1212\/01.wnl.0000176067.32186.a3","volume":"6","author":"FE Somnier","year":"2005","unstructured":"Somnier FE (2005) Increasing incidence of late-onset anti-AChR antibody seropositive myast henia gravis. Neurology 6:928\u2013930","journal-title":"Neurology"},{"key":"1159_CR14","first-page":"87","volume":"1","author":"MI Uono","year":"1980","unstructured":"Uono MI (1980) Clinical statistics of myasthenia gravis in Japan. Int J Neurol 1:87\u201399","journal-title":"Int J Neurol"},{"key":"1159_CR15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S0092-8674(00)81251-9","volume":"4","author":"TM DeChiara","year":"1996","unstructured":"DeChiara TM, Bowen DC, Valenzuela DM, Simmons MV, Poueymirou WT, Thomas S, Kinetz E, Compton DL, Rojas E, Park JS, Smith C, DiStefano PS, Glass DJ, Burden SJ, Yancopoulos GD (1996) The receptor tyrosine kinase MuSk is required for neuromuscular junction formation in vivo. Cell 4:501\u2013512","journal-title":"Cell"},{"key":"1159_CR16","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1212\/01.WNL.0000129274.12702.92","volume":"11","author":"K Ohta","year":"2004","unstructured":"Ohta K, Shigemoto K, Kubo S, Maruyama N, Abe Y, Ueda N, Ohta M (2004) MuSk antibodies in AChR Ab-seropositive MG vs AChR Ab-seronegative MG. Neurology 11:2132\u20132133","journal-title":"Neurology"},{"key":"1159_CR17","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/j.1468-1331.2005.01137.x","volume":"6","author":"F Romi","year":"2005","unstructured":"Romi F, Aarli JA, Gilhus NE (2005) Seronegative myasthenia gravis: disease severity and prognosis. Eur J Neurol 6:413\u2013418","journal-title":"Eur J Neurol"},{"key":"1159_CR18","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1212\/01.wnl.0000254620.45529.97","volume":"8","author":"F Deymeer","year":"2007","unstructured":"Deymeer F, Gungor-Tuncer O, Yilmaz V, Parman Y, Serdaroglu P, Ozdemir C, Vincent A, Saruhan-Direskeneli G (2007) Clinical comparison of anti-MuSk- vs anti-AChR-positive and seronegative myasthenia gravis. Neurology 8:609\u2013611","journal-title":"Neurology"},{"key":"1159_CR19","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1212\/01.WNL.0000150587.71497.B6","volume":"3","author":"L Lauriola","year":"2005","unstructured":"Lauriola L, Ranelletti F, Maggiano N, Guerriero M, Punzi C, Marsili F, Bartoccioni E, Evoli A (2005) Thymus changes in anti-MuSk-positive and negative myasthenia gravis. Neurology 3:536\u2013538","journal-title":"Neurology"},{"key":"1159_CR20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0022-510X(02)00200-9","volume":"1\u20132","author":"M Baets De","year":"2002","unstructured":"De Baets M, Stassen MH (2002) The role of antibodies in myasthenia gravis. J Neurol Sci 1\u20132:5\u201311","journal-title":"J Neurol Sci"}],"container-title":["Neurological Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-012-1159-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10072-012-1159-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10072-012-1159-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,11]],"date-time":"2020-07-11T10:50:58Z","timestamp":1594464658000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10072-012-1159-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,7,25]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2013,6]]}},"alternative-id":["1159"],"URL":"https:\/\/doi.org\/10.1007\/s10072-012-1159-x","relation":{},"ISSN":["1590-1874","1590-3478"],"issn-type":[{"value":"1590-1874","type":"print"},{"value":"1590-3478","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,7,25]]}}}